Recombinant Prostate Cancer Susceptibility Candidate (PRAC)

Size 10 µg 50 µg 100 µg 200 µg 500 µg 1 mg

SKU:TRV-034856-01

$130.00

Sale Sold out

Shipping calculated at checkout.

Recombinant Prostate Cancer Susceptibility Candidate (PRAC) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.

Related categories: Recombinants

View full details

Product specifications

Alternative Name	C17orf92; Prostate, Rectum And Colon; Small nuclear protein PRAC1; Prostate cancer susceptibility candidate protein 1; Prostate, rectum and colon expressed gene protein
Name Synonym	Prostate Cancer Susceptibility Candidate
Uniprot	Q96KF2
Field of Research	Tumor immunity
Applications	Positive Control; Immunogen; SDS-PAGE; WB.
Organism Species	Homo sapiens (Human)
Form	Freeze-dried powder
Buffer	PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Tag	N-terminal His and GST Tag
Fragment	Met1~Pro57
Host	E. coli
Host or Source	E.coli
Source	Prokaryotic expression
Expression System	Prokaryotic expression
Calculated Molecular Weight	36kDa
Observed Molecular Weight	36kDa
Isoelectripoint	9.9
Subcellular Location	Nucleus
Purity	> 90%
Endotoxin	<1.0EU per 1μg (determined by the LAL method)

Your cart is empty

Your cart

Estimated total

Recombinant Prostate Cancer Susceptibility Candidate (PRAC)

Product specifications

Country/region

Country/region

Recombinant Prostate Cancer Susceptibility Candidate (PRAC)

Product specifications

Related Research Products

Subscribe to our emails